Prevention of Early-onset Neonatal Group B Streptococcal Disease
Overview
Affiliations
Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is an opportunistic pathogen that colonizes the gastrointestinal and genitourinary tracts of up to 50% of healthy adults and newborns; it is responsible for significant morbidity and mortality. Early detection can be used to establish the use of antibiotic prophylaxis to significantly reduce neonatal sepsis. This article reviews methods of detection and prevention of GBS infection in the neonate.
Updates on Group B Infection in the Field of Obstetrics and Gynecology.
Choi Y, Han H, Chong G, Le T, Nguyen H, Lee O Microorganisms. 2022; 10(12).
PMID: 36557651 PMC: 9780959. DOI: 10.3390/microorganisms10122398.
Hume-Nixon M, Ratu T, Clark S, Nguyen C, Neal E, Pell C BMJ Open. 2022; 12(12):e061157.
PMID: 36456016 PMC: 9716885. DOI: 10.1136/bmjopen-2022-061157.
Li X, Ding X, Shi P, Zhu Y, Huang Y, Li Q Medicine (Baltimore). 2019; 98(12):e14686.
PMID: 30896617 PMC: 6709008. DOI: 10.1097/MD.0000000000014686.
Winn C, Bakthavatchalu V, Esmail M, Feng Y, Dzink-Fox J, Richey L J Med Microbiol. 2017; 67(1):97-109.
PMID: 29160197 PMC: 5884963. DOI: 10.1099/jmm.0.000627.
Katoba J, Hangulu L, Mashamba-Thompson T BMJ Open. 2017; 7(11):e017884.
PMID: 29102993 PMC: 5695340. DOI: 10.1136/bmjopen-2017-017884.